EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring

Na Zhang, Nan Bai, Ying Wang, Beibei Liang, Yun Cai iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s547979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Na Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, PLA General Hospital, Beijing, 100853, People's Republic of Ch…. Hauptthemen laut MEDLINE: Drug Monitoring, Oxazolidinones, Linezolid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oxazolidinone antimicrobials, which are effective against multidrug-resistant gram-positive pathogens, face challenges of variable efficacy and safety owing to patient pharmacokinetic differences.

Purpose

This study aimed to establish a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to simultaneously quantify multiple oxazolidinone antimicrobials, including linezolid, tedizolid, and contezolid, for therapeutic drug monitoring (TDM) applications.

Methods

Chromatographic separation was achieved on a C18 column (100 × 2.1 mm, 3.5 μm) with gradient elution. Detection was performed via positive electrospray ionization (ESI+) in multiple reaction monitoring (MRM) mode, targeting transitions: m/z 338.14→162.8 (linezolid); m/z 371→343.1 (tedizolid) and m/z 409.15→269.14 (contezolid), with voriconazole-d3 as the internal standard.

Results

The method was validated using Bioanalytical Method Validation (M10). The method demonstrated high selectivity and wide linear ranges of 50.0-15,000.0 ng/mL for linezolid and contezolid, and 25.0-7500.0 ng/mL for tedizolid, respectively, with a good linearity (R2 > 0.993). The intra- and inter-day accuracy and precision were within acceptable limits. Recovery ranged from 94.4% to 104.2% in plasma, and matrix effects were negligible (CV%

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringOxazolidinonesLinezolidHumansTandem Mass SpectrometryChromatography, LiquidLiquid Chromatography-Mass SpectrometryTetrazoles

Stichwörter der Autor:innen

LC-MS/MScontezolidlinezolidoxazolidinonetedizolid

Substanzen

OxazolidinonesLinezolidtedizolidTetrazoles

Autor:innen und Institutionen

  • Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, PLA General Hospital, Beijing, 100853, People's Republic of China.

ORCID-Profile: Yun Cai

Zitieren

APA

Zhang, N., Bai, N., Wang, Y., Liang, B., & Cai, Y. (2025). LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s547979

Vancouver

Zhang N, Bai N, Wang Y, Liang B, Cai Y. LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s547979

BibTeX
@article{Zhang2025,
  author = {Zhang, Na and Bai, Nan and Wang, Ying and Liang, Beibei and Cai, Yun},
  title = {LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s547979}
}
Kostenlos starten →